AU2001270098A1 - Recombination modulators and methods for their production and use - Google Patents

Recombination modulators and methods for their production and use

Info

Publication number
AU2001270098A1
AU2001270098A1 AU2001270098A AU7009801A AU2001270098A1 AU 2001270098 A1 AU2001270098 A1 AU 2001270098A1 AU 2001270098 A AU2001270098 A AU 2001270098A AU 7009801 A AU7009801 A AU 7009801A AU 2001270098 A1 AU2001270098 A1 AU 2001270098A1
Authority
AU
Australia
Prior art keywords
modulators
recombination
production
methods
recombination modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270098A
Inventor
Clemencia Pinilla
Anca Segall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
San Diego State University Research Foundation
Original Assignee
STATE SAN DIEGO, University of
San Diego State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STATE SAN DIEGO, University of, San Diego State University Research Foundation filed Critical STATE SAN DIEGO, University of
Publication of AU2001270098A1 publication Critical patent/AU2001270098A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001270098A 2000-06-22 2001-06-21 Recombination modulators and methods for their production and use Abandoned AU2001270098A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60208700A 2000-06-22 2000-06-22
US09/602,087 2000-06-22
PCT/US2001/020046 WO2001098540A2 (en) 2000-06-22 2001-06-21 Recombination modulators and methods for their production and use

Publications (1)

Publication Number Publication Date
AU2001270098A1 true AU2001270098A1 (en) 2002-01-02

Family

ID=24409912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270098A Abandoned AU2001270098A1 (en) 2000-06-22 2001-06-21 Recombination modulators and methods for their production and use

Country Status (5)

Country Link
US (1) US20040002441A1 (en)
EP (1) EP1328658A2 (en)
AU (1) AU2001270098A1 (en)
CA (1) CA2412513A1 (en)
WO (1) WO2001098540A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310270D0 (en) * 2003-05-03 2003-06-11 Univ Edinburgh Biomolecular devices
GB0424953D0 (en) 2004-11-11 2004-12-15 Plant Bioscience Ltd Assay
KR100879220B1 (en) * 2007-11-12 2009-01-19 아주대학교산학협력단 Antimicrobial peptide kcm21 against phytopathogenic bacteria
US9795551B2 (en) * 2014-06-26 2017-10-24 L'oreal Tetrapeptides and a method of use as an antioxidant
CN115362165A (en) * 2020-03-11 2022-11-18 安尼根有限公司 Antidiabetic and antiobesity composition comprising novel compounds
KR20230037391A (en) * 2021-09-09 2023-03-16 애니젠 주식회사 Composition for preventing or treating inflammatory bowl disease comprising novel compound

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175810A (en) * 1979-03-30 1984-10-09 Frank A. Momany Synthetic peptides having pituitary growth hormone releasing activity
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
EP0288965A2 (en) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptides with a phospholipase A2 inhibiting activity
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
CA2090860C (en) * 1990-11-21 2003-09-16 Richard A. Houghten Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
DE69205466T2 (en) * 1991-03-21 1996-05-30 Procter & Gamble Skin wrinkle control agent containing the Arg-Ser-Arg-Lys sequences.
GB9125024D0 (en) * 1991-11-25 1992-01-22 Kirby Julian Rheumatoid arthritus treatment
US5440016A (en) * 1993-06-18 1995-08-08 Torrey Pines Institute For Molecular Studies Peptides of the formula (KFmoc) ZZZ and their uses
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
US6222024B1 (en) * 1994-05-24 2001-04-24 The Trustees Of Columbia University In The City Of New York Nucleic acids encoding a human immunodeficiency virus type 1 (HIV-1) integrase interactor protein (INI-1)
US5885782A (en) * 1994-09-13 1999-03-23 Nce Pharmaceuticals, Inc. Synthetic antibiotics
US5602097A (en) * 1994-09-13 1997-02-11 Ceres Technologies, Inc. Synthetic antibiotics
DE69535882D1 (en) * 1994-12-30 2008-12-18 Univ Georgetown FLUORESCENT TEST FOR DETECTING THE CLEAVAGE OF NUCLEIC ACID
WO1997000889A1 (en) * 1995-06-21 1997-01-09 Asahi Kasei Kogyo Kabushiki Kaisha Peptides binding to low-density lipoproteins
AU724158B2 (en) * 1995-12-13 2000-09-14 Syngenta Limited Antifungal proteins
US6013505A (en) * 1996-10-08 2000-01-11 Smithkline Beecham Corporation Topoisomerase I
EP0866075B1 (en) * 1997-02-19 2004-10-27 Arpida AG, Method to treat microbial infections by uncoupling of phosphotransferase system and appropriate agents therefor
US6329501B1 (en) * 1997-05-29 2001-12-11 Auburn University Methods and compositions for targeting compounds to muscle
DE19753182A1 (en) * 1997-11-21 1999-07-29 Claas Junghans Topologically fixed matrix-bound nucleic acid
EP1053358A4 (en) * 1998-02-10 2002-08-14 Uab Research Foundation The use of hiv-1 integrase in screening hiv-1 drug candidates
US5998152A (en) * 1998-03-09 1999-12-07 Tularik Inc. High-throughput screening assays for modulators of nucleic acid topoisomerases
CA2324344A1 (en) * 1998-03-25 1999-09-30 The Procter & Gamble Company Fluorescent assay for topoisomerase inhibitors
EP1085846A2 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
JP2002519332A (en) * 1998-06-26 2002-07-02 エヌ・ヴェー・ニュートリシア Pharmaceutical preparation for use in treating or preventing surface infections caused by microorganisms
FR2786501B1 (en) * 1998-11-30 2003-02-07 Aventis Pharma Sa PROTEIN PARTNER OF HUMAN TOPOISOMERASE IIIa
AU784063B2 (en) * 1999-09-22 2006-01-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA)
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
AU2001275423B2 (en) * 2000-06-09 2007-01-11 Regulon, Inc. Encapsulation of polynucleotides and drugs into targeted liposomes

Also Published As

Publication number Publication date
US20040002441A1 (en) 2004-01-01
CA2412513A1 (en) 2001-12-27
WO2001098540A3 (en) 2003-04-24
WO2001098540A2 (en) 2001-12-27
EP1328658A2 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
AU2001252612A1 (en) Ppargamma modulators
AU2001288623A1 (en) Fxr modulators
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001294030A1 (en) Fibre and its production
AU2002211717A1 (en) Stresscopins and their uses
AU2001243394A1 (en) Compounds and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001296709A1 (en) Gemstone
AU2000270441A1 (en) Advertising method
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001270098A1 (en) Recombination modulators and methods for their production and use
AU2001274530A1 (en) Lot distributing method
AU2001264134A1 (en) Microconnectors and method for their production
AUPQ583100A0 (en) Fastening apparatus and methods for their production and use
AU2001266176A1 (en) Methods
EP1147748A3 (en) Endocanal pin for dental use and relative production method
AU2001237530A1 (en) Method
AU2001278951A1 (en) Compounds and methods
AU2002218440A1 (en) New process
AU2001210572A1 (en) Ornament
AU2001241636A1 (en) Halotherapy method
AU2001250536A1 (en) Methods
AU2002256556A1 (en) Sea-trosy and related methods